SLC1A2 and Alzheimer disease: Others have found thicker and longer processes in astrocytes in resilient donors compared to both AD and control donors and increased Glutamate transporter-1 (GLT-1) expression in astrocytes in resilient and control donors compared to AD patients in the entorhinal cortex [83].